Cargando…
A label‐free impedance assay in endothelial cells differentiates the activation and desensitization properties of clinical S1P(1) agonists
Sphingosine‐1 phosphate receptor‐1 (S1P(1)) activation maintains endothelial barrier integrity, whereas S1P(1) desensitization induces peripheral blood lymphopenia. The latter is exploited in the approval and/or late‐stage development of receptor‐desensitizing agents targeting the S1P(1) receptor in...
Autores principales: | Grailhe, Patrick, Boutarfa‐Madec, Asma, Beauverger, Philippe, Janiak, Philip, Parkar, Ashfaq A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7530392/ https://www.ncbi.nlm.nih.gov/pubmed/32810927 http://dx.doi.org/10.1002/2211-5463.12951 |
Ejemplares similares
-
A G-protein-biased S1P(1) agonist, SAR247799, improved LVH and diastolic function in a rat model of metabolic syndrome
por: Evaristi, Maria Francesca, et al.
Publicado: (2022) -
Agonist-induced internalization and desensitization of the apelin receptor
por: Pope, George R., et al.
Publicado: (2016) -
Agonist-Directed Desensitization of the β(2)-Adrenergic Receptor
por: Goral, Vasiliy, et al.
Publicado: (2011) -
Endothelial‐protective effects of a G‐protein‐biased sphingosine‐1 phosphate receptor‐1 agonist, SAR247799, in type‐2 diabetes rats and a randomized placebo‐controlled patient trial
por: Bergougnan, Luc, et al.
Publicado: (2020) -
Label-free impedance flow cytometry for nanotoxicity screening
por: Ostermann, Melanie, et al.
Publicado: (2020)